Unichem gets 5 observations from USFDA for Goa formulation facility
Drug Approval

Unichem gets 5 observations from USFDA for Goa formulation facility

The inspection closed with five observations which were more of procedural changes with none of these related to data integrity

  • By IPP Bureau | July 17, 2024

The United States Food and Drug Administration (USFDA) conducted an inspection at the Unichem Laboratory's Goa formulation facility from 8th July 2024 to 15th July 2024.

The inspection closed with five observations which were more of procedural changes with none of these related to data integrity.

The Company will provide the necessary response with in stipulated 15 working days. The observations do not impact business continuity and the Company's supplies to the US market.

Upcoming E-conference

Other Related stories

Startup

Digitization